HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q3 2024

SEC EDGAR SourceSEC Filings

Top Holdings48 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ONCONC
ADR

BEIGENE LTD-ADR

5.2M$1.2B25.5%$134.02+62.97%
24 qtrssince 2018-Q4
Unchanged
0
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

8.8M$936.8M20.6%$83.58+23.73%
10 qtrssince 2022-Q2
Increased
91
PDDPDD
ADR

PDD HOLDINGS INC

4.8M$642.6M14.1%$97.08+39.46%
10 qtrssince 2022-Q2
Decreased
0
LEGNLEGN
ADR

Legend Biotech Corp. Sponsored ADR

6.6M$323.4M7.1%$50.33-2.10%
18 qtrssince 2020-Q2
Unchanged
0
VIPSVIPS
ADR

VIPSHOP HLDGS LTD

15.7M$247.3M5.4%$12.69+19.66%
15 qtrssince 2021-Q1
Increased
65
NTESNTES
ADR

NETEASE INC-ADR

2.6M$242.1M5.3%$90.10+0.72%
8 qtrssince 2022-Q4
Increased
94
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

10.9M$216.4M4.8%$21.97-10.84%
17 qtrssince 2020-Q3
Decreased
0
TCOMTCOM
ADR

TRIP.COM GROUP LTD-ADR

1.8M$105.5M2.3%$49.90+22.28%
2 qtrssince 2024-Q2
Increased
65

ARRIVENT BIOPHARMA INC

4.5M$105.4M2.3%$17.95+28.17%
3 qtrssince 2024-Q1
Unchanged
0
FUTUFUTU
ADR

FUTU HLDGS LTD

1.1M$100.5M2.2%$70.34+19.00%
2 qtrssince 2024-Q2
Increased
71
ZTOZTO
ADR

ZTO EXPRESS CAYMAN INC

3M$74.4M1.6%$23.65-0.02%
7 qtrssince 2023-Q1
Increased
76
JDJD
ADR

JD.COM INC-ADR

1.6M$64M1.4%$38.63+0.35%
24 qtrssince 2018-Q4
Increased
76
ENFNENFNDelisted

ENFUSION INC

5M$47.2M1.0%
12 qtrssince 2021-Q4
Unchanged
0

KINIKSA PHARMACEUTICALS INTL

1.6M$39.6M0.9%$18.67+33.90%
2 qtrssince 2024-Q2
Decreased
0

CYTEK BIOSCIENCES INC

6.7M$36.9M0.8%$20.96-74.28%
13 qtrssince 2021-Q3
Unchanged
0
BIDUBIDU
ADR

BAIDU INC - SPON ADR

300,000$31.6M0.7%$105.170.00%
1 qtr
New
57

YUM CHINA HOLDINGS INC -W/I

665,863$30M0.7%$44.730.00%
1 qtr
New
57

BRIDGEBIO PHARMA INC

1M$26.1M0.6%$28.21-11.58%
22 qtrssince 2019-Q2
Decreased
0
YSYSG
ADR

YATSEN HLDG LTD

7M$23.8M0.5%$10.59-68.18%
16 qtrssince 2020-Q4
Unchanged
0
HTHTHTHT
ADR

H WORLD GROUP LTD

568,613$21.2M0.5%$42.46-15.85%
18 qtrssince 2020-Q2
Unchanged
0
$4.6B
AUM
48
Positions
Q3 2024
Filing
Rating · 2.0
Quarterly Portfolio Change
-17%Q2'23$4.7B-5%Q3'23$4.5B+11%Q4'23$5B-7%Q1'24$4.6B-12%Q2'24$4.1B+12%Q3'24$4.6B
Activity profile
$ moved · Q3'24
New3%Increased47%Decreased37%Exited13%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.9 years
<1Q4%1-4Q25%1-2Y10%2Y+60%

HHLR ADVISORS, LTD. manages $4.6B across 48 positions as of Q3 2024. Top holdings: ONC (25.5%), BABA (20.6%), PDD (14.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q3 2024 Summary

Active quarter - 4 new positions, 34 exits, 7 increased. Top move: NTES (INCREASED, conviction 94). Portfolio: $4.6B across 48 positions.

Top holdings by portfolio weight

Total AUM$5B
ONC25.52%
BABA20.57%
PDD14.11%
LEGN7.10%
VIPS5.43%
NTES5.31%
BEKE4.75%
TCOM2.31%
AVBP2.31%
FUTU2.21%
Other1.63%

Portfolio allocation by GICS sector

Sectors9
Consumer Cyclical45.06%
Healthcare37.98%
Communication Services6.33%
Real Estate4.75%
Financial Services2.22%
Industrials1.71%
Unknown1.30%
Consumer Defensive0.52%
Technology0.13%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Consumer Cyclical, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used